28 Jun

Macao Gaming Stock Continues Recovery In June

WRITTEN BY Ally Schmidt

Stock movement

Major Macao casinos Sands China (LVS), Galaxy Entertainment (GXYEY), Melco Resorts & Entertainment (MLCO), MGM Resorts (MGM), and Wynn Resorts (WYNN) have been on the rise since September 2016, when casino revenue started rebounding. The recovery has continued into June 2017, with Macao casinos posting strong growth in their May gaming revenue.

Macao Gaming Stock Continues Recovery In June

In June 2017, Las Vegas Sands has had the highest gain of 8.5%, followed by MGM Resorts with a gain of 6.3% and Wynn Resorts with a gain of 5.4%. Melco gained 0.57%. The VanEck Vectors Gaming ETF (BJK) gained close to 3.4%, and the broader market, replicated by the SPDR S&P 500 ETF (SPY), remained flat.

Year-to-date performance

As of June 27, 2017, Wynn had posted the highest YTD (year-to-date) gain of 56.8%. Melco followed, with a gain of 42.8. Las Vegas Sands gained 20.1%, and MGM Resorts gained 17%. BJK posted a gain of 21.5%, and SPY gained ~8.0%.

Series overview

In this series, we’ll discuss how the gaming industry in Macao has been performing lately by analyzing key indicators such as gross gaming revenue and visitor arrivals. We’ll also take a look at how the Chinese economy could affect companies in Macao.

Latest articles

On November 14, The George Soros Fund Management LLC filed 13F. The firm's total market value was around $3.6 billion at the end of Q3 2019.

Tesla (TSLA) stock short sellers seem to be getting exasperated. Notably, Tesla stock has been the short sellers’ favorite.

In the week that ended on November 15, natural gas prices fell 3.5% and settled at 2.688 per MMBtu (million British thermal units).

The Dow Jones Index (DIA) and S&P 500 (SPY) are trading at record highs and on Friday the Dow Jones crossed the 28,000 level for the first time.

Goldman Sachs (GS) settled a lawsuit that alleged it rigged bond prices. Also, Deutsche Bank agreed to pay a fine of $15 million to settle a lawsuit.

In the November 15 premarket trading session, Amarin Corporation (AMRN) stock rose more than 7%, caused by the FDA positive decision for Vascepa.